Recommendations

Document Overview

Design and created by Guideline Central in participation with the American Society of Breast Surgeons.

Use of Transcutaneous and Percutaneous Ablation for the Treatment of Benign and Malignant Tumors of the Breast

American Society of Breast Surgeons

Publication Date: Feb 24, 2026

Page Last Updated: May 5, 2026

Document Overview

Document Title: Use of Transcutaneous and Percutaneous Ablation for the Treatment of Benign and Malignant Tumors of the Breast

Authoring Society: American Society of Breast Surgeons

Document Publication Date: Feb 24, 2026

Page Last Reviewed/Updated: May 5, 2026

Document Type: Consensus Statement

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: www.breastsurgeons.org/docs/statements/asbrs-treatment-of-benign-and-malignant-tumors-of-the-breast-2026-02-24.pdf

Document Scope, Criteria, and Use Cases

Document Objectives: The purpose of this document is to outline current data on transcutaneous and percutaneous ablation methods for treatment of benign and malignant tumors of the breast.

Scope: Management, Treatment

Diseases/Conditions (MeSH)

D001943 - Breast Neoplasms

D018226 - Fibroadenoma

D001943 - Breast Neoplasms

D018226 - Fibroadenoma

Keywords: Percutaneous Ablation, Transcutaneous Ablation, Tumors of the Breast, fibroadenomas

Inclusion Criteria: Male, Female, Adult, Older Adult

Health Care Settings: Operating and Recovery Room, Outpatient, Radiology Services

Intended Users: Clinical Researcher, Nurse, Nurse Practitioner, Physician, Physician Assistant, Radiology Technologist